AuroMedics Recalls Linezolid Injection Bags Due to Sterility Concerns
AuroMedics Pharma LLC is recalling Linezolid Injection bags due to a lack of assurance of sterility and a confirmed report of leaking bags with mold.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The recall is classified as FDA Class II and involves a confirmed report of mold and leaking bags, which poses a significant risk of serious injury or infection to patients receiving intravenous medication.
Plain-English summary
AuroMedics Pharma LLC is recalling 39,515 bags of Linezolid Injection 600 mg per 300 mL (2 mg/mL) for intravenous administration. The product is manufactured by Aurobindo Pharma Limited in India for AuroMedics Pharma, LLC. The recall covers specific lot numbers with expiration dates ranging from July 2018 to October 2019.
The recall was initiated due to a lack of assurance of sterility. A confirmed customer report indicated that bags were leaking and mold was found between the outer bag and the overwrap. The affected product was distributed nationwide in the United States.
Healthcare providers and patients should stop using the affected Linezolid Injection bags immediately. The FDA classifies this as a Class II recall, indicating that use of, or exposure to, the violative product may cause temporary or medically reversible adverse health consequences.
The recalled product
- Product
- LINEZOLID (LINEZOLID)
- Brand
- LINEZOLID
- Manufacturer
- AuroMedics Pharma LLC
- Category
- Drug — Antibiotic Injection
- Affected units
- 395,150
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (20)
- Lot/Batch #'s: CLZ160001
- CLZ160002
- CLZ160003
- CLZ160004 exp July 2018
- CLZ160005
- CLZ160006
- CLZ160008
- CLZ160009
- CLZ160010 and CLZ160012
- exp August 2018
- CLZ160013
- CLZ160014
- CLZ160015
- CLZ160016
- exp October 2018
- CLZ160017
- CLZ160018
- CLZ160019
- CLZ160021
- CLZ160022
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 7 recalled by AuroMedics Pharma LLC under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 7 products in this recall →Related recalls
Same brand · LINEZOLID
- CriticalAuroMedics Recalls Linezolid Injection Bags Due to Mold Contamination
FDA (Drugs) · 2018-02-14
Same manufacturer · AuroMedics Pharma LLC
See all →- HighFondaparinux Sodium Injection Recalled Nationwide for Subpotent Formulation
FDA (Drugs) · 2022-11-02
- HighAcyclovir Sodium Injectable Recalled for Particulate Matter
FDA (Drugs) · 2022-10-26
- LowTranexamic Acid Injection Recalled for Metal Particulate Matter
FDA (Drugs) · 2022-10-12
- SeverePolymyxin B for Injection Recalled Due to Particulate Matter Contamination
FDA (Drugs) · 2022-02-16
- SevereAuroMedics Recalls Acetaminophen Injection Due to Discoloration and pH Failures
FDA (Drugs) · 2021-02-10
Same hazard · contamination
See all →- HighMedline Recalls Surgical Convenience Kits Due to Contaminated Components
FDA (Devices) · 2026-09-02
- HighMedline Recalls 263 Surgical Convenience Kits Due to Contamination
FDA (Devices) · 2026-09-02
- HighMedline Recalls 71 Convenience Kits Due to Contaminated Component
FDA (Devices) · 2026-09-02
- HighMedline C-Section Convenience Kits Recalled for Contaminated Components
FDA (Devices) · 2026-09-02
- HighMedline Recalls 419 Surgical Kits Due to Contaminated Component
FDA (Devices) · 2026-09-02